The Role of 18F-FDG-PET/CT in the Management of Patients with High-Risk Breast Cancer: Case Series and Guideline Comparison - Advances in Molecular Imaging

AMI > Vol.4 No.3, July 2014

Volume 4, Issue 3 (July 2014)

ISSN Print: 2161-6728 ISSN Online: 2161-6752

Google-based Impact Factor: 0.54 Citations

The Role of ¹⁸F-FDG-PET/CT in the Management of Patients with High-Risk Breast Cancer: Case Series and Guideline Comparison ()

HTML XML

Download as PDF (Size: 2314KB) PP. 35-41

DOI: 10.4236/ami.2014.43005 3,953 Downloads 5,134 Views

Author(s)

Ben F. Bulten, Marie J. de Haas, Haiko J. Bloemendal, Adriaan J. van Overbeeke, Jan Paul Esser, Henk J. Baarslag, Lioe-Fee de Geus-Oei, C. J. Rodenburg, John M. H. de Klerk

Affiliation(s)

Department of Oncology, Meander Medical Centre, Amersfoort, The Netherlands.
Department of Radiology and Nuclear Medicine, Meander Medical Centre, Amersfoort, The Netherlands.
Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
Department of Radiology, Meander Medical Centre, Amersfoort, The Netherlands.
Department of Surgery, Meander Medical Centre, Amersfoort, The Netherlands.

ABSTRACT

Objectives: In grade III-IV breast cancer, dissemination of disease needs to be assessed. Until now this was done by conventional imaging (liver ultrasonography, chest X-ray and bone scintigraphy), but evidence favoring the use of FDG-PET/CT is accumulating. Methods: Patients with high-risk breast cancer, who had received conventional imaging and FDG-PET/CT, were included. Patients were staged and assigned a treatment after 1) conventional imaging and 2) FDG-PET/CT, both by a multidisciplinary oncology team. Equivocal FDG-PET/CT findings were histologically confirmed. Results: 16 patients were included (mean age 59 years). TNM-stage changed in 5 patients (31%) after FDG-PET/CT. In 3 patients (19%) unknown distant metastases were detected by FDG-PET/CT. An adjustment of treatment took place in 4 patients (25%). Conclusions: Our case series emphasizes the role of FDG-PET/CT in the staging of high-risk breast carcinoma, especially in the assessment of distant metastases. We suggest replacing conventional imaging with FDG-PET/CT.

KEYWORDS

Breast Cancer, FDG-PET/CT, Staging, Dissemination, Guidelines

Share and Cite:

F. Bulten, B. , J. de Haas, M. , J. Bloemendal, H. , J. van Overbeeke, A. , Paul Esser, J. , J. Baarslag, H. , de Geus-Oei, L. , J. Rodenburg, C. and M. H. de Klerk, J. (2014) The Role of ¹⁸F-FDG-PET/CT in the Management of Patients with High-Risk Breast Cancer: Case Series and Guideline Comparison. Advances in Molecular Imaging, 4, 35-41. doi: 10.4236/ami.2014.43005.

Cited by

No relevant information.

Journals Menu

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies